1 / 6

Women’s Health Study: Vitamin E in Primary Prevention

Women’s Health Study: Vitamin E in Primary Prevention. Women’s Health Study: Vitamin E in Primary Prevention. Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Julie E. Buring Orlando, Florida. Women's Health Study: Vitamin E in Primary Prevention.

tracey
Télécharger la présentation

Women’s Health Study: Vitamin E in Primary Prevention

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Women’s Health Study: Vitamin E in Primary Prevention Women’s Health Study: Vitamin E in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Julie E. Buring Orlando, Florida

  2. Women's Health Study: Vitamin E in Primary Prevention 39,876 initially healthy† women age ≥ 45 Randomized, blinded, factorial • Placebo • n=19,939 • Vitamin E • 600 IU on alternate days • n=19,937 • Primary Endpoints (mean 10.1 years): • Combined endpoint of nonfatal MI, nonfatal stroke, and total cardiovascular death • Incidence of total malignant neoplasms of epithelial cell origin †: No history of coronary heart disease, cerebrovascular disease, cancer (except nonmelanoma skin cancer), or other major chronic illness; no history of side effects to any of the study medications; not taking aspirin or nonsteroidal antiinflammatory medications (NSAIDs) more than once a week (or were willing to forego their use during the trial); not taking anticoagulants or corticosteroids; and not taking individual supplements of vitamin A, E, or beta carotene more than once a week. Presented at ACC 2005

  3. Women's Health Study: Vitamin E in Primary Prevention Primary Composite Endpoint: Major Cardiovascular Events Relative Risk [RR] 0.93 95% CI 0.82-1.05 p=0.26 Composite Components: Stroke p=0.82 MI p=0.96 Death from CV Causes p=0.03 • Among the individual components of the composite endpoint, there was no difference in MI or stroke, but total cardiovascular death was significantly lower in the vitamin E group. • In subgroup analysis, there was no modification of the primary endpoint results among women with high level of compliance, women using HRT, or by menopausal status. Presented at ACC 2005

  4. Women's Health Study: Vitamin E in Primary Prevention Components of Stroke Ischemic Stroke p=0.88 Hemorrhagic Stroke p=0.68 • There was no difference in total stroke Presented at ACC 2005

  5. Women's Health Study: Vitamin E in Primary Prevention Side Effects: Gastrointestinal Bleeding p=0.77 • Gastrointestinal bleed rate did not differ between the vitamin E group and the placebo group Presented at ACC 2005

  6. Women’s Health Study: Vitamin E in Primary Prevention: Summary • Among initially healthy women, treatment with vitamin E was not associated with a significant difference in the primary endpoint of major cardiovascular events compared with placebo at a mean 10 year follow-up. • Randomized trials of vitamin E for secondary prevention did not demonstrate benefit as shown in the large Heart Protection Study. These findings, along with data from the earlier Heart Protection Study, do not support use of vitamin E for prevention of cardiovascular disease. • The reduction of cardiovascular death associated with vitamin E use will require further exploration, as there was no decrease in fatal MI or fatal stroke. Presented at ACC 2005

More Related